Martin Shkreli, the former CEO of Turing Pharmaceuticals who raised the price of an anti-parasitic drug fiftyfold, will appear before the House Oversight Committee Thursday morning for a hearing on drug pricing.
The controversial 32-year-old, who was subpoenaed to appear at the hearing by the committee, plans to assert his Fifth Amendment right, his attorney Benjamin Brafman told ABC News.
The hearing comes a day after Shkreli, who is facing unrelated securities fraud charges, appeared in federal court in New York City.
As CEO of Turing, Shkreli presided over the purchase of Daraprim -- an established drug used to treat parasitic infections. The drug's price was exponentially raised overnight. He stepped down from that post in December after his arrest on the securities fraud charges.
House lawmakers accuse Turing -- along with Valeant Pharmaceuticals -- of raising drug prices in search of profit. Rep. Elijah Cummings (D-MD), the top Democrat on the panel, released a series of e-mails from both companies Tuesday, saying they illustrated how the drug price increases were profit-minded from the the start, despite the company's public comments.
This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.
from ABC News: Politics http://ift.tt/1P8KHOK
via IFTTT
0 Response to "Former Turing CEO Martin Shkreli to Plead the Fifth on Capitol Hill"
Posting Komentar